Association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and cardiovascular mortality among US adults with diabetes: a prospective cohort study of NHANES 1999–2018
This prospective cohort study of US adults with diabetes found a modest, nonlinear association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and cardiovascular mortality, where higher NHHR values above an apparent nadir of approximately 2.5–3.0 were linked to an increased risk, though the findings warrant cautious interpretation and further validation.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
For millions of people living with diabetes, the greatest threat to their lives often comes not from high blood sugar itself, but from the silent damage it does to the heart and blood vessels. Doctors have long known that managing cholesterol is critical in this fight, but the picture is complicated. There is the "bad" cholesterol that clogs arteries and the "good" cholesterol that helps clear them away. For years, medical advice has focused on measuring these two types separately. However, a growing number of researchers believe that looking at the balance between them—the ratio of the bad to the good—might tell a more complete story about a person's risk. This balance acts like a single score that captures the entire landscape of a person's lipid health, potentially revealing dangers that individual numbers might miss.
A team of researchers set out to test this idea using a massive, decades-long collection of health data from the United States. They turned to the National Health and Nutrition Examination Survey, a program that has been tracking the health of a representative group of Americans since 1999. By linking the blood test results from ten different cycles of this survey to national death records, the scientists could follow the lives of thousands of adults with diabetes for up to twenty years. Their goal was to see if the ratio of non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol could predict who would eventually die from heart disease. They were not just looking for a simple "more is worse" pattern; they wanted to know if the relationship was more complex, perhaps curving in unexpected ways that could change how doctors think about risk.
The study followed 6,581 adults with diabetes, carefully tracking their blood work and their vital status until the end of 2019. During this time, 622 of these participants died from cardiovascular causes. When the researchers grouped the participants based on their cholesterol ratios, they found that the risk of dying from heart disease did not rise in a straight, predictable line. Instead, the data suggested a curve. The risk appeared to be lowest when the ratio was somewhere between 2.5 and 3.0. Below this range, the risk was not significantly higher, but as the ratio climbed above this point, the danger of cardiovascular death began to creep upward.
This pattern held true even after the researchers accounted for other major factors that influence heart health, such as age, sex, race, income, body mass index, smoking history, and high blood pressure. When they compared the group with the highest cholesterol ratios to the group with the lowest, the risk of death was about 31 percent higher, though the statistical certainty of this specific comparison was not absolute. The trend was clearer when looking at the data in steps: for every step up in the ratio groups, the risk of death increased by about 11 percent. This suggests that while a very high ratio is a warning sign, the relationship is not a simple straight line, and the lowest risk seems to sit in a specific middle ground rather than at the very bottom of the scale.
The researchers were careful to note that these findings are suggestive rather than definitive. When they tested the results by removing the first two years of follow-up to rule out early deaths from other causes, or when they added blood sugar control levels to their calculations, the strength of the connection weakened slightly, and the statistical significance was attenuated, though the direction of the trend remained the same. This tells us that while the link between a high cholesterol ratio and heart death appears in the data, the association was modest and less precise in these sensitivity analyses. The study did not prove that lowering this ratio will automatically save lives, nor did it establish a specific target number that every patient should aim for.
Ultimately, this work adds a new layer of understanding to the complex puzzle of diabetes and heart disease. It suggests that the balance between bad and good cholesterol may matter, but it also warns that the story is not a simple one. The data points to a sweet spot where risk is lowest, with danger rising as the balance tips too far toward the bad cholesterol. While these results are not yet a final answer for clinical practice, they provide a compelling reason for doctors and patients to pay closer attention to this specific ratio. The study concludes that more research is needed, ideally with repeated blood tests over time and detailed records of medication use, to confirm whether this ratio can serve as a reliable guide for protecting the hearts of people with diabetes.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.